Maude, S. L., Grupp, S. A., Pulsipher, M. A., Rives, S., Myers, G. D., Verneris, M. R., … Levine, J. (2017). ANALYSIS OF SAFETY DATA FROM 2 MULTICENTER TRIALS OF CTL019 IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED/REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL). In HAEMATOLOGICA (Vol. 102, pp. 197–198). Madrid, SPAIN: FERRATA STORTI FOUNDATION.

Maude, S. L., S. A. Grupp, M. A. Pulsipher, S. Rives, G. D. Myers, M. R. Verneris, J. Buechner, et al. “ANALYSIS OF SAFETY DATA FROM 2 MULTICENTER TRIALS OF CTL019 IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED/REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL).” In HAEMATOLOGICA, 102:197–98. FERRATA STORTI FOUNDATION, 2017.

Maude SL, Grupp SA, Pulsipher MA, Rives S, Myers GD, Verneris MR, et al. ANALYSIS OF SAFETY DATA FROM 2 MULTICENTER TRIALS OF CTL019 IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED/REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL). In: HAEMATOLOGICA. FERRATA STORTI FOUNDATION; 2017. p. 197–8.

Maude, S. L., et al. “ANALYSIS OF SAFETY DATA FROM 2 MULTICENTER TRIALS OF CTL019 IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED/REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL).” HAEMATOLOGICA, vol. 102, FERRATA STORTI FOUNDATION, 2017, pp. 197–98.

Maude SL, Grupp SA, Pulsipher MA, Rives S, Myers GD, Verneris MR, Buechner J, Laetsch TW, Bittencourt H, Boyer M, De Moerloose B, Qayed M, Davies S, Martin PL, Bader P, Schlis K, Wood P, Taran T, Zhang Y, Leung M, June CH, Levine J. ANALYSIS OF SAFETY DATA FROM 2 MULTICENTER TRIALS OF CTL019 IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED/REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL). HAEMATOLOGICA. FERRATA STORTI FOUNDATION; 2017. p. 197–198.